Abbott Labs (ABT) PT Raised to $136 at Credit Suisse on Covid Testing Revenue
Tweet Send to a Friend
Credit Suisse analyst Matt Miksic raised the price target on Abbott Labs (NYSE: ABT) to $136.00 (from $109.00) while raising ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
